Published • loading... • Updated
PreDiabeTx: Swiss Precision Digital Therapeutics for the Prevention of Type-2 Diabetes
Summary by CDHI
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PreDiabeTx: Swiss Precision Digital Therapeutics for the Prevention of Type-2 Diabetes
All Projects PreDiabeTx: Swiss Precision Digital Therapeutics for the Prevention of Type-2 Diabetes Type 2 diabetes is a common disease of affluence. Around half a million people in Switzerland are affected by this chronic metabolic disorder – and the trend is rising. In type 2 diabetes, the body’s response to the hormone insulin is impaired. Blood sugar levels rise – and with them the risk of numerous complications, including heart attacks and …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
